You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

squamous immunophenotype

Showing 1 - 25 of 2,507
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022

Gastric Cancer, Bladder Cancer, Squamous NSCLC Trial in Poland (CPL304110)

Recruiting
  • Gastric Cancer
  • +6 more
  • Gdańsk, Poland
  • +6 more
Mar 9, 2022

Esophageal Cancer Trial in Beijing (3DCRT)

Recruiting
  • Esophageal Cancer
  • 3DCRT
  • Beijing, Beijing, China
    Department of Radiation Oncology, National Cancer Center/Nationa
Sep 13, 2022

Oral Cavity Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab)

Active, not recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Amsterdam, Noord-Holland, Netherlands
    VU University medical center
Oct 6, 2021

Sepsis, Septic Shock, Sepsis Syndrome Trial in Nanjing

Enrolling by invitation
  • Sepsis
  • +2 more
    • Nanjing, Jiangsu, China
      Department of Critical Care , Zhong-da Hospital
    Oct 29, 2022

    DxFLEX 10C Clinical Study

    Enrolling by invitation
    • Hematological Malignancy
    • DxFLEX 10C
    • Aliso Viejo, California
    • +5 more
    Jul 19, 2022

    Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and

    Recruiting
    • HNSCC
    • +6 more
    • Conventional Therapy acc. to prevailing clincal approved schemes
    • Erlangen, Bavaria, Germany
      Department of Radiation Oncology, Universitätsklinikum Erlangen
    May 18, 2021

    The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

    Recruiting
    • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
    • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
    • Hanzhou, Zhejiang, China
      Lulu Liu
    Jul 14, 2023

    Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Skin
    • Carrilizumab with albumin-binding paclitaxel
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    May 23, 2023

    Advanced Esophageal Squamous Cell Carcinoma Trial in Beijing, Xiamen, Xinxiang (Afatinib, Irinotecan)

    Recruiting
    • Advanced Esophageal Squamous Cell Carcinoma
    • Beijing, China
    • +2 more
    Apr 6, 2023

    Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
    • (no location specified)
    Mar 17, 2023

    Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

    Recruiting
    • Metastatic Esophageal Squamous Cell Carcinoma
    • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
    • Qingdao, Shandong, China
    • +1 more
    Nov 13, 2023

    NSCLC Trial in United States

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Daphne, Alabama
      • +16 more
      May 30, 2023

      Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

      Not yet recruiting
      • Squamous Cell Carcinoma
        • San Francisco, California
          Power Life Sciences
        Jun 23, 2023

        Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

        Recruiting
        • Esophageal Squamous Cell Carcinoma
        • Head and Neck Squamous Cell Carcinoma
        • Chengdu, Sichuan, China
          West China Hospital, Sichuan University
        Oct 25, 2023

        Needs and Preferences of Patients With Head-neck Cutaneous SCC

        Active, not recruiting
        • Cutaneous Squamous Cell Carcinoma
        • +10 more
        • Regular care with additional administration of a semi-structured interview
        • Maastricht, Netherlands
          Maastricht University Medical Center+
        Sep 13, 2023

        Non Squamous Non Small Cell Lung Cancer, EGFR Positive NSCLC Trial (Toripalimab plus Chemotherapy)

        Not yet recruiting
        • Non Squamous Non Small Cell Lung Cancer
        • EGFR Positive Non-small Cell Lung Cancer
        • Toripalimab plus Chemotherapy
        • (no location specified)
        Jul 28, 2023

        Advanced Solid Tumors Trial in Australia, China (Sitravatinib)

        Completed
        • Advanced Solid Tumors
        • Blacktown, New South Wales, Australia
        • +16 more
        Jan 10, 2023

        Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma, Locally Advanced Cutaneous

        Active, not recruiting
        • Recurrent Head and Neck Squamous Cell Carcinoma
        • +3 more
        • 200 mg Pembrolizumab
        • +2 more
        • Miami, Florida
        • +6 more
        Jan 9, 2023

        Immune-related Adverse Events Refractory to Standard Therapy and

        Recruiting
        • Immune-related Adverse Event
        • Extracorporeal photopheresis
        • Other immunosuppressive or immunomodulatory drugs
        • Munich, Germany
          LMU Klinikum Hauttumorzentrum
        Jan 17, 2023

        Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

        Recruiting
        • Squamous Cell Carcinoma of Oral Cavity
        • +3 more
        • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
        • Gliwice, Silesia, Poland
          The Maria Sklodowska-Curie National Research Institute of Oncolo
        Aug 7, 2023

        Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

        Not yet recruiting
        • Locally Advanced Head and Neck Squamous Cell Carcinoma
        • (no location specified)
        Mar 20, 2023

        Endoscopic Submucosal Dissection Versus Esophagectomy for Early

        Completed
        • Esophageal Cancer
        • Endoscopic submucosal dissection
        • Esophagectomy
        • Shanghai, China
          Changhai Hospital, Naval Medical University
        Sep 27, 2023

        Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

        Not yet recruiting
        • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
        • Guangzhou, Guangdong, China
          Sun Yat-sen University
        Oct 24, 2023

        Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

        Not yet recruiting
        • Head and Neck Squamous Cell Carcinoma
        • PET/CT
        • Neck dissection
        • (no location specified)
        Jan 31, 2023